Donor-Derived Genotype 4 Hepatitis E Virus Infection, Hong Kong, China, 2018
Siddharth Sridhar, Vincent C.C. Cheng, Shuk-Ching Wong, Cyril C.Y. Yip, Shusheng Wu, Anthony W.I. Lo, Kit-Hang Leung, Winger W.N. Mak, Jianpiao Cai, Xin Li, Jasper F.W. Chan, Susanna K.P. Lau, Patrick C.Y. Woo, Wai-Ming Lai, Tze-Hoi Kwan, Timmy W.K. Au, Chung-Mau Lo, Sally C.Y. Wong, and Kwok-Yung Yuen
Author affiliations: The University of Hong Kong, Hong Kong, China (S. Sridhar, V.C.C. Cheng, S.-C. Wong, C.C.Y. Yip, S. Wu, K.-H. Leung, W.W.N. Mak, J. Cai, X. Li, J.F.W. Chan, S.K.P. Lau, P.C.Y. Woo, C.-M. Lo, S.C.Y. Wong, K.-Y. Yuen); Queen Mary Hospital, Hong Kong (A.W.I. Lo, T.W.K. Au); Princess Margaret Hospital, Hong Kong (W.-M. Lai); Tuen Mun Hospital, Hong Kong (T.-H. Kwan)
Main Article
Figure 2
Figure 2. Timeline of outbreak in study of donor-derived genotype 4 HEV infection, Hong Kong, China, 2018, showing baseline HEV IgG status of each organ recipient. White bars indicate incubation period during which liver function test results were within reference range. Gray bars indicate timeline of alanine aminotransferase derangement after transplantation. X indicates patient death. Vertical arrows (↑) indicate time of hepatitis E diagnosis. HEV, hepatitis E virus.
Main Article
Page created: February 19, 2019
Page updated: February 19, 2019
Page reviewed: February 19, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.